-

Form 8.3 - International Paper Company

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

22-10-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

7,000,923

2.01

(2) Cash-settled derivatives:

 

0

0.0

0

0.0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

700

0.0001

7,100

0.002

 

TOTAL:

700

0.0001

7,008,023

2.01

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

Common Stock

Sale

10

47.05

Common Stock

Sale

11

47.62

Common Stock

Sale

22

47.49

Common Stock

Sale

26

47.34

Common Stock

Sale

55

47.52

Common Stock

Sale

56

47.53

Common Stock

Sale

58

47.52

Common Stock

Sale

72

47.26

Common Stock

Sale

79

47.53

Common Stock

Sale

100

46.89

Common Stock

Sale

100

46.90

Common Stock

Sale

100

46.91

Common Stock

Sale

100

47.02

Common Stock

Sale

100

47.12

Common Stock

Sale

100

47.14

Common Stock

Sale

100

47.29

Common Stock

Sale

100

47.39

Common Stock

Sale

100

47.44

Common Stock

Sale

100

47.48

Common Stock

Sale

100

47.51

Common Stock

Sale

100

47.66

Common Stock

Sale

100

47.66

Common Stock

Sale

105

47.25

Common Stock

Sale

110

47.40

Common Stock

Sale

126

47.03

Common Stock

Sale

131

47.48

Common Stock

Sale

146

46.97

Common Stock

Sale

150

47.35

Common Stock

Sale

150

47.50

Common Stock

Sale

151

47.48

Common Stock

Sale

159

47.07

Common Stock

Sale

163

47.69

Common Stock

Sale

168

47.19

Common Stock

Sale

168

47.31

Common Stock

Sale

187

47.06

Common Stock

Sale

200

47.05

Common Stock

Sale

200

47.56

Common Stock

Sale

200

47.59

Common Stock

Sale

200

47.61

Common Stock

Sale

204

46.99

Common Stock

Sale

210

47.52

Common Stock

Sale

216

47.49

Common Stock

Sale

223

47.42

Common Stock

Sale

234

47.43

Common Stock

Sale

249

47.00

Common Stock

Sale

249

47.01

Common Stock

Sale

254

47.23

Common Stock

Sale

274

47.17

Common Stock

Sale

296

47.18

Common Stock

Sale

300

46.87

Common Stock

Sale

316

47.69

Common Stock

Sale

321

47.36

Common Stock

Sale

337

47.66

Common Stock

Sale

343

47.38

Common Stock

Sale

352

47.08

Common Stock

Sale

369

47.22

Common Stock

Sale

378

47.04

Common Stock

Sale

400

47.41

Common Stock

Sale

403

47.15

Common Stock

Sale

415

47.16

Common Stock

Sale

424

46.98

Common Stock

Sale

477

47.68

Common Stock

Sale

494

46.95

Common Stock

Sale

508

47.09

Common Stock

Sale

555

47.13

Common Stock

Sale

590

47.67

Common Stock

Sale

600

47.12

Common Stock

Sale

635

47.10

Common Stock

Sale

645

47.11

Common Stock

Sale

653

46.96

Common Stock

Sale

695

47.49

Common Stock

Sale

701

47.59

Common Stock

Sale

722

47.63

Common Stock

Sale

781

47.64

Common Stock

Sale

825

47.37

Common Stock

Sale

899

47.46

Common Stock

Sale

900

47.55

Common Stock

Sale

935

47.45

Common Stock

Sale

953

47.20

Common Stock

Sale

988

47.51

Common Stock

Sale

1007

47.21

Common Stock

Sale

1095

47.54

Common Stock

Sale

1189

47.62

Common Stock

Sale

1195

47.65

Common Stock

Sale

1200

47.58

Common Stock

Sale

1303

47.52

Common Stock

Sale

1466

47.58

Common Stock

Sale

1500

47.55

Common Stock

Sale

1593

47.47

Common Stock

Sale

1842

47.54

Common Stock

Sale

1980

47.59

Common Stock

Sale

2140

47.60

Common Stock

Sale

2165

47.48

Common Stock

Sale

2253

47.61

Common Stock

Sale

3097

47.52

Common Stock

Sale

3574

47.50

Common Stock

Sale

4701

47.49

Common Stock

Sale

4992

47.56

Common Stock

Sale

5988

47.57

Common Stock

Sale

6058

47.55

Common Stock

Sale

8173

47.51

Common Stock

Sale

18212

47.53

Common Stock

Purchase

1

47.01

Common Stock

Purchase

1

47.16

Common Stock

Purchase

9

46.85

Common Stock

Purchase

11

46.96

Common Stock

Purchase

32

47.48

Common Stock

Purchase

34

47.37

Common Stock

Purchase

40

47.02

Common Stock

Purchase

52

47.51

Common Stock

Purchase

53

46.98

Common Stock

Purchase

69

46.84

Common Stock

Purchase

84

46.98

Common Stock

Purchase

91

47.62

Common Stock

Purchase

96

47.05

Common Stock

Purchase

100

47.05

Common Stock

Purchase

100

47.08

Common Stock

Purchase

100

47.10

Common Stock

Purchase

100

47.12

Common Stock

Purchase

100

47.47

Common Stock

Purchase

110

47.09

Common Stock

Purchase

129

46.95

Common Stock

Purchase

136

47.06

Common Stock

Purchase

138

47.14

Common Stock

Purchase

146

47.02

Common Stock

Purchase

167

46.90

Common Stock

Purchase

181

46.94

Common Stock

Purchase

205

47.13

Common Stock

Purchase

205

47.54

Common Stock

Purchase

231

47.57

Common Stock

Purchase

278

47.17

Common Stock

Purchase

309

47.56

Common Stock

Purchase

470

46.97

Common Stock

Purchase

507

47.52

Common Stock

Purchase

2413

46.87

Common Stock

Purchase

15003

47.53

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

23-10-2024

Contact name:

Stuart Brown

Telephone number:

00442070722969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Call option

IP US 04/17/25 C50 Equity

Purchase

200

USD 50

American

04/17/25

Common Stock

Call option

IP US 01/17/25 C47.5 Equity

Purchase

200

USD 47.5

American

01/17/25

Common Stock

Put option

IP US 04/17/25 P45 Equity

Purchase

-300

USD 45

American

04/17/25

Common Stock

Call option

IP US 04/17/25 C47.5 Equity

Purchase

300

USD 47.5

American

04/17/25

Common Stock

Put option

IP US 04/17/25 P47.5 Equity

Purchase

-2,200

USD 47.5

American

04/17/25

Common Stock

Put option

IP US 01/16/26 P42.5 Equity

Purchase

-4,600

USD 42.5

American

01/16/26

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

Contacts

Qube Research & Technologies LTD

Qube Research & Technologies LTD

LSE:0JCB

Release Versions

Contacts

Qube Research & Technologies LTD

More News From Qube Research & Technologies LTD

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a tru...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
Back to Newsroom